Abstract
Orphenadrine is an anticholinergic drug used mainly in the treatment of Parkinson's disease. It has a peripheral and central effect and a known cardiotoxic effect when taken in large doses. We report the successful outcome of the treatment of a 2 1/2-year-old girl who accidentally ingested 400 mg of orphenadrine hydrochloride (Disipal). One hour after ingestion she presented neurological symptoms: confusion, ataxic walking, and periods of severe agitation. Generalized tonic-clonic seizures appeared resistant to the administration of multiple antiepileptics. They ceased after a supplementary dose of intravenous diazepam, endotracheal intubation, and mechanical ventilation. An episode of ventricular tachycardia responded well to i. v. lidocaine. Physostigmine was administered in three successive doses. The initial orphenadrine plasma level (3,55 μg/ml) was in the toxic range, associated with high mortality. The calculated elimination half-life was 10.2 h and the molecule and/or its metabolites were found up to 90 h after ingestion.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 11 August 1998/Final revision received: 11 April 1999/Accepted: 13 April 1999
Rights and permissions
About this article
Cite this article
Van Herreweghe, I., Mertens, K., Maes, V. et al. Orphenadrine poisoning in a child: clinical and analytical data. Intensive Care Med 25, 1134–1136 (1999). https://doi.org/10.1007/s001340051024
Issue Date:
DOI: https://doi.org/10.1007/s001340051024